#ITI#Recombinant Hemagglutinin of Avian Influenza Virus H5 Expressed in the Chloroplast of Chlamydomonas reinhardtii and Evaluation of Its Immunogenicity in Chickens#FTI#
#IRE#SUMMARY Globally, avian influenza (AI) is a serious problem in poultry farming. Despite vaccination, the prevalence of AI in México highlights the need for new approaches to control AI and to reduce the economic losses associated with its occurrence in susceptible birds. Recombinant proteins from avian influenza virus (AIV) have been expressed in different organisms, such as plants. The present study investigated the feasibility of designing and expressing the HA protein of AIV in the transplastomic microalga Chlamydomonas reinhardtii as a novel approach for AIV control and taking advantage of culture conditions, its reproductive range, and safe use in consideration of the generally regarded as safe food ingredient regulatory classification. The results showed that the HA protein of AIV in C. reinhardtii presents antigenic activity by western blot test and through its application in chickens, demonstrating its feasibility as a recombinant antigen against AIV. © 2016 American Association of Avian Pathologists.#FRE#
#IPC#chicken; Chlamydomonas reinhardtii; chloroplast; hemagglutinin; influenza A virus; recombinant protein#FPC#
#IRF#Aguilar-Yanez J.M., Portillo-Lara R., Mendoza-Ochoa G.I., Garcia-Echauri S.A., Lopez-Pacheco F., Bulnes-Abundis D., Salgado-Gallegos J., Lara-Mayorga I.M., Webb-Vargas Y., Leon-Angel F.O., Rivero-Aranda R.E., Oropeza-Almazan Y., Ruiz-Palacios M G., Zertuche-Guerra M.I., DuBois M R., White S.W., Schultz-Cherry S., Russell C.J., Alvarez M.M., An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli, PLoS One, 5, (2010); 
Amorij J.P., Meulenaar J., Hinrichs W.L., Stegmann T., Huckriede A., Coenen F., Frijlink H.W., Rational design of an influenza subunit vaccine powder with sugar glass technology: Preventing conformational changes of haemagglutinin during freezing and freeze-drying, Vaccine, 25, pp. 6447-6457, (2007); 
Beltran-Lopez J.I., Romero-Maldonado A., Monreal-Escalante E., Banuelos-Hernandez B., Paz-Maldonado L.M., Rosales-Mendoza S., Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies, Plant Cell. Rep., 35, pp. 1133-1141, (2016); 
Bertran K., Thomas C., Guo X., Bublot M., Pritchard N., Regan J.T., Cox K.M., Gasdaska J.R., Dickey L.F., Kapczynski D.R., Swayne D.E., Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens, Vaccine, 33, pp. 3456-3462, (2015); 
Bosch F.X., Orlich M., Klenk H.D., Rott R., The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses, Virology, 95, pp. 197-207, (1979); 
Breiman A., Fawcett T.W., Ghirardi M.L., Mattoo A.K., Plant organelles contain distinct peptidylprolyl cis, trans-isomerases, J. Biol. Chem., 267, pp. 21293-21296, (1992); 
Cox E., Verdonck F., Vanrompay D., Goddeeris B., Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa, Vet. Res., 37, pp. 511-539, (2006); 
Daniell H., Ruiz O.N., Dhingra A., Chloroplast genetic engineering to improve agronomic traits, Methods Mol. Biol., 286, pp. 1111-1138, (2005); 
Danon A., Mayfield S.P., Light-regulated translation of chloroplast messenger RNAs through redox potential, Science, 266, pp. 1717-1719, (1994); 
Dauvillee D., Delhaye S., Gruyer S., Slomianny C., Moretz S.E., D'Hulst C., Long C.A., Ball S.G., Tomavo S., Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules, PLoS One, 5, (2010); 
De Geus E.D., Degen W.G., Van Haarlem D.A., Schrier C., Broere F., Vervelde L., Distribution patterns of mucosally applied particles and characterization of the antigen presenting cells, Avian Pathol., 44, pp. 222-229, (2015); 
Denis J., Acosta-Ramirez E., Zhao Y., Hamelin M.E., Koukavica I., Baz M., Abed Y., Savard C., Pare C., Lopez Macias C., Boivin G., Leclerc D., Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform, Vaccine, 26, pp. 395-403, (2008); 
Dreesen I.A., Charpin-El Hamri G., Fussenegge M., Heatstable oral alga-based vaccine protects mice from Staphylococcus aureus infection, J. Biotechnol., 145, pp. 273-280, (2010); 
DuBois R.M., Aguilar-Yanez J.M., Mendoza-Ochoa G.I., Oropeza-Almazan Y., Schultz-Cherry S., Alvarez M.M., White S.W., Russell C.J., The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure, J. Virol., 85, pp. 865-872, (2011); 
Fernandez-Siurob I., Retana M.A., Tellez G., Arroyo-Navarro L., Banuelos-Hernandez B., Castellanos-Huerta I., Assessment of viral interference using a chemical receptor blocker against avian influenza and establishment of protection levels in field outbreaks, Vaccine, 32, pp. 1318-1322, (2014); 
Franklin S.E., Mayfield S.P., Prospect for molecular farming in the green alga Chlamydomonas reinhardtii, Curr. Opin. Plant Biol., 7, pp. 159-165, (2004); 
Gorman D.S., Levine R.P., Cytochrome f and plastocyanin: Their sequence in the photosynthetic electron transport chain of Chlamydomonas reinhardi, Proc. Natl. Acad. Sci. U. S. A., 54, pp. 1665-1669, (1965); 
He D.M., Qian K.X., Shen G.F., Zhang Z.F., Li Y.N., Su Z.L., Shao H.B., Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chloroplasts, Colloids Surf. B Biointerfaces, 55, pp. 26-30, (2007); 
Houser K., Subbarao K., Influenza vaccines: Challenges and solutions, Cell Host Microbe, 17, pp. 295-300, (2015); 
Khurana S., Verma S., Verma N., Crevar C.J., Carter D.M., Manischewitz J., King L.R., Ross T.M., Golding H., Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus, PLoS One, 5, (2010); 
Khurana S., Verma S., Verma N., Crevar C.J., Carter D.M., Manischewitz J., King L.R., Ross T.M., Golding H., Bacterial HA1 vaccine against pandemic H5N1 influenza virus: Evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets, J. Virol., 85, pp. 1246-1256, (2011); 
Kilbourne E.D., Influenza pandemics of the 20th century, Emerg. Infect. Dis., 12, pp. 9-14, (2006); 
Landry N., Pillet S., Favre D., Poulin J.F., Trepanier S., Yassine-Diab B., Ward B.J., Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens, Clin. Immunol., 154, pp. 164-177, (2014); 
Landry N., Ward B.J., Trepanier S., Montomoli E., Dargis M., Lapini G., Vezina L.P., Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza, PLoS One, 5, (2010); 
Lee M.D., Lawrence H.A., Colibacillosis, A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 14-16, (1989); 
Li R., Chowdhury M.Y., Kim J.H., Kim T.H., Pathinayake P., Koo W.S., Park M.E., Yoon J.E., Roo J.B., Hong S.P., Sung M.E., Lee J.S., Kim C.J., Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) induce broadly protective immune responses against divergent influenza subtypes, Vet. Microbiol., 179, pp. 250-263, (2015); 
Luo L., Nishi K., MacLeod E., Sabara M.I., Expression and characterization of HA1 protein of highly pathogenic H5N1 avian influenza virus for use in a serodiagnostic assay, Transbound. Emerg. Dis., (2015); 
Manuell A.L., Beligni M.V., Elder J.H., Siefker D.T., Tran M., Weber A., McDonald T.L., Mayfield S.P., Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast, Plant Biotechnol. J., 5, pp. 402-412, (2007); 
Mayfield S.P., Franklin S.E., Lerner R.A., Expression and assembly of a fully active antibody in algae, Proc. Natl. Acad. Sci. U. S. A., 100, pp. 438-442, (2003); 
Miller P.J., Koch G., Newcastle disease, other avian Paramyxoviruses, and avian Metapneumovirus infections; Newcastle disease, Diseases of Poultry, pp. 89-138, (2013); 
Mortimer E., Maclean J.M., Mbewana S., Buys A., Williamson A.L., Hitzeroth I.I., Rybicki E.P., Setting up a platform for plant-based influenza virus vaccine production in South Africa, BMC Biotechnol., 12, (2012); 
Mussgnug J.H., Genetic tools and techniques for Chlamydomonas reinhardtii, Appl. Microbiol. Biotechnol., 99, pp. 5407-5418, (2015); 
Neumann G., Kawaoka Y., Transmission of influenza A viruses, Virology, 479-480, pp. 234-246, (2015); 
New N., He Q., Damrongwatanapokin S., Du Q., Manopo I., Limlamthong Y., Fenner B.J., Spencer L., Kwang J., Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture, BMC Microbiol., 6, (2006); 
Olah I., Vervelde L., Structure in the avian lymphoid system, Avian Immunology, pp. 13-50, (2008); 
Olsen C.W., McGregor M.W., Dybdahl-Sissoko N., Schram B.R., Nelson K.M., Lunn D.P., Macklin M.D., Swain W.F., Hinshaw V.S., Immunogenicity and efficacy of baculovirus-expressed and DNAbased equine influenza virus hemagglutinin vaccines in mice, Vaccine, 15, pp. 1149-1156, (1997); 
Peach M., Marsh N., Miskiewicz E.I., MacPhee D.J., Solubilization of proteins: The importance of lysis buffer choice, Methods Mol. Biol., 1312, pp. 49-60, (2015); 
Schat K.A., Purchase H.G., Cell-culture methods, A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 223-234, (1989); 
Qiu D., Tannock G.A., Barry R.D., Jackson D.C., Western blot analysis of antibody responses to influenza virion proteins, Immunol. Cell Biol., 70, pp. 181-191, (1992); 
Rasala B.A., Muto M., Lee P.A., Jager M., Cardoso R.M., Behnke C.A., Kirk P., Hokanson C.A., Crea R., Mendez M., Mayfield S.P., Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii, Plant Biotechnol. J., 8, pp. 719-733, (2010); 
Rosales-Mendoza S., Paz-Maldonado L.M., Soria-Guerra R.E., Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: Current status and perspectives, Plant Cell Rep., 31, pp. 479-494, (2012); 
Schroda M., The Chlamydomonas genome reveals its secrets: Chaperone genes and the potential roles of their gene products in the chloroplast, Photosynth. Res., 82, pp. 221-240, (2004); 
Schwartzman L.M., Cathcart A.L., Pujanauski L.M., Qi L., Kash J.C., Taubenberger J.K., An intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza A virus, MBio, 6, pp. e01044-e01115, (2015); 
Shane S.M., Avian influenza, Handbook on Poultry Diseases, pp. 87-92, (2005); 
Singh M., Briones M., O'Hagan D.T., A novel bioadhesive intranasal delivery system for inactivated influenza vaccines, J. Control. Release, 70, pp. 267-276, (2001); 
Spackman E.A., Brief introduction to the avian influenza virus, Methods Mol. Biol., 1161, pp. 61-68, (2014); 
Specht E., Miyake-Stoner S., Mayfield S., Micro-algae come of age as a platform for recombinant protein production, Biotechnol. Lett., 32, pp. 1373-1383, (2010); 
Steel J., New strategies for the development of H5N1 subtype influenza vaccines: Progress and challenges, BioDrugs, 25, pp. 285-298, (2011); 
Sun M., Qian K., Su N., Chang H., Liu J., Shen G., Foot-andmouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast, Biotechnol. Lett., 25, pp. 1087-1092, (2003); 
Suzuki Y., Ito T., Suzuki T., Holland R.E., Chambers T.M., Kiso M., Ishida H., Kawaoka Y., Sialic acid species as a determinant of the host range of influenza A viruses, J. Virol., 74, pp. 11825-11831, (2000); 
Swayne D.E., Suarez D.L., Sims L.D., Influenza, Diseases of Poultry, pp. 181-218, (2013); 
Tran M., Henry R.E., Siefker D., Van C., Newkirk G., Kim J., Bui J., Mayfield S.P., Production of anti-cancer immunotoxins in algae: Ribosome inactivating proteins as fusion partners, Biotechnol. Bioeng., 110, pp. 2826-2835, (2013); 
Tran M., Zhou B., Pettersson P.L., Gonzalez M.J., Mayfield S.P., Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts, Biotechnol. Bioeng., 104, pp. 663-673, (2009); 
Van Ginkel F.W., Tang D.C., Gulley S.L., Toro H., Induction of mucosal immunity in the avian harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin, Dev. Comp. Immunol., 33, pp. 28-34, (2009); 
Vana G., Westover K.M., Origin of the 1918 Spanish influenza virus: A comparative genomic analysis, Mol. Phylogenet. Evol., 47, pp. 1100-1110, (2008); 
Villegas P., Titration of biological suspension, A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 248-253, (1989); 
Vitova M., Bisova K., Hlavova M., Kawano S., Zachleder V., Cizkova M., Chlamydomonas reinhardtii: Duration of its cell cycle and phases at growth rates affected by temperature, Planta, 234, pp. 599-608, (2011); 
Wagner R., Heuer D., Wolff T., Herwig A., Klenk H.D., NGlycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication, J. Gen. Virol., 83, pp. 601-609, (2002); 
Webster R.G., Hinshaw V.S., Bean W.J., Turner B., Shortridge K.F., Influenza viruses from avian and porcine sources and their possible role in the origin of human pandemic strains, Dev. Biol. Stand., 39, pp. 461-468, (1977); 
Westphal O.J., Bacterial lipopolysaccharides: Extraction with phenol-water and further application of the procedure, Methods Carbohydr. Chem., 5, pp. 83-91, (1965); 
Manual on Avian Influenza Diagnosis and Surveillance, pp. 37-39, (2002); 
Worrall E.E., Sudarisman, Priadi A., Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry, Vaccine, 27, pp. 4161-4168, (2009); 
Wu C.Y., Yeh Y.C., Yang Y.C., Chou C., Liu M.T., Wu H.S., Chan J.T., Hsiao P.W., Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus, PLoS One, 5, (2010); 
Zar J., Biostatistical Analysis, pp. 348-351, (1984)#FRF#
